Watch VideoThe Oxford-Astrazeneca vaccine trial has some good news after early data found its candidate is working well in older adults.
The University of Oxford says the shot is safe and that it triggered a strong immune response in people over 70 who are typically more vulnerable to the virus. They plan to release the...
Oxford-AstraZeneca Vaccine Shows Promise In Elderly
Newsy
0 shares
1 views
You might like
Related news coverage
Moderna boss says its COVID-19 vaccine should be given to vulnerable
Proactive Investors
Moderna Inc (NASDAQ:MRNA) has confirmed its COVID-19 vaccine achieved a 94% success in its recent phase III trial and that it will..
-
India could get Oxford COVID-19 vaccine by April 2021: Serum Institute chief
Mid-Day
-
News24.com | WATCH | AstraZeneca Covid shot shows promise in elderly
News24
-
AstraZeneca COVID-19 vaccine shows promise in elderly, trial results expected by Christmas
CBC.ca
-
AstraZeneca COVID-19 vaccine shows promise in elderly
Sydney Morning Herald
Advertisement
More coverage
AstraZeneca COVID-19 shot candidate shows promise among elderly in trials
Results of late-stage trials of University of Oxford's COVID-19 vaccine candidate should definitely be known by Christmas.
Jerusalem Post
AstraZeneca and Oxford University: Confirms immune response in elderly, phase 3 vaccine trial results in weeks
Read more on https://www.fxstreet.com
FXstreet.com